ENG
Active B12 Test Market Global Industry Analysis and Forecast (2025-2032)
Active B12 Test Market size was valued at USD 227.24 Mn. in 2024 and the Active B12 Test revenue is expected to grow at a CAGR of 24.7% from 2025 to 2032, reaching nearly USD 1328.67 Mn. by 2032.
Format : PDF | Report ID : SMR_2051
Active B12 Test Market Overview:
Vitamin B12 deficiency is a serious health issue among the elderly population. It is no longer a rare kind of disease; it prevails as a common condition in the elderly population. Vegetarians mainly suffer from vitamin B12 deficiency for the reason that natural source of vitamin B12 mainly comprises of food from the animal origin. A B12 test is a blood test used to determine the B12 levels in your body. Vitamin B12 helps to produce red blood cells, which prevents anaemia, which causes weakness and exhaustion. It also plays a role in neurological function by governing the amounts of chemicals called neurotransmitters, which move nerve impulses from one cell to another.
The global active B12 testing market is growing gradually because of rising consumer awareness of pernicious anaemia, adult macrocytic Lancia, and folate deficiency. The main driver impacting the active B12 global market is the growth of vitamin deficiencies among patients because of changed lifestyle choices, such as smoking, poor eating, and lack of exercise. Further, the global market is expected to benefit from increased patient awareness regarding the disparity in the health problems of patients and the potential observed benefits of active B12.
To get more Insights: Request Free Sample Report
Active B12 Test Market Dynamics:
Rising B12 Deficiency in the Population is Driving the Growth of Active B12 Test Market.
Increasing incidence of vitamin B12 deficient disorders is driving the market growth of active B12 testing. Active B12 Test, has been closely watched by end-users like doctors, hospitals, and diagnostic labs because of increasing numbers of adult cases of macrocytic Lancia-related conditions like folic acid deficiency or vitamin B12 deficiencies in many parts of the world. In addition, the rise of macrocytic Lancia among expecting mothers resulting from a deficiency of dietary intake during pregnancy provide a fulfilling demand in terms of both volume and value. The growing awareness among consumers about adult macrocytic Lancia, pernicious anaemia, and folate insufficiency is leading to an increase in the global market for active B12 testing, driving the Active B12 Test Market growth.
Technical and Regulatory Factors Affect the Growth of the Active B12 Test Market.
One of the biggest issues for Active B12 Testing industry is ensuring that the Active B12 tests provide accurate and consistent results. Standardization is crucial because differences in test kits and methods lead to inconsistent results. A more complex procedure with advanced equipment and knowledge is required for the active B12 test compared with the total B12 test, and these limit its general application. Justification for widespread use becomes relevant because new diagnostic test certification processes are costly to develop. Further, the process entails much time and is made more complicated by different requirements in different locations. Continuous adherence to the requirements and standards of regulation is also important.
This includes post-market surveillance, manufacturing processes, and quality control. Active B12 testing also reflect in clinical guidelines before it is allowed to be used in clinical practice. Adoption process is also slow where there is weak support from medical societies. All these factors are affecting the growth of the Active B12 Test Market.
Active B12 Test Market Segment Analysis:
By Test Type, ELISA test held the largest Active B12 Test Market share in 2024. It is to be expected, since ELISA tests are recommended by all guidelines for performing B12 testing because ELISA assays, because of their excellent sensitivity, specificity, and ease of use, are so effective and reliable for the detection of active B12 levels critical in both vitamin B12 deficiency diagnosis and therapy that they are used very widely in clinical labs. ELISA is well known and trusted test in the world, which is recommended by so many physicians around the world. All these factors are driving the growth of the segment in the market.
Active B12 Test Market Regional Insight:
North America accounts for the largest share in the active B12 test market in 2024, ensuring that it retains the leading regional position. This is primarily attributed to the highly developed healthcare system, which is among the regions important attributes alongside high awareness of vitamin deficiency and the well-established diagnostics industry. Increasing morbidity because of vitamin B12 deficiency as a result of changing dietary practices and a rise in the number of people affected by chronic diseases also remains a key driver for the active B12 test market in North America. Availability and adoption of modern diagnostic tests in the region are further inspired by the presence of key market players and continuous research and development that has always led the region to take the first position in the Active B12 Test Market. All these factors are propelling the growth of the market in the region.
Active B12 Test Market Competitive Landscape:
- In March 2024, Axis-Shield Diagnostics announced the acquisition of a leading biotech firm specializing in vitamin deficiency diagnostics. This strategic move aims to expand Axis-Shield’s portfolio of diagnostic tests, particularly in the Active B12 Test Market.
- In April 2024, Abbott launched an innovative Active B12 Test kit designed for enhanced accuracy and ease of use in clinical settings. This new product features advanced assay technology that provides faster and more reliable results, catering to the increasing demand for precise vitamin B12 diagnostics.
|
Active B12 Test Market |
|
|
Market Size in 2024 |
USD 227.24 Mn. |
|
Market Size in 2032 |
USD 1328.67 Mn. |
|
CAGR (2025-2032) |
24.7 % |
|
Historic Data |
2019-2024 |
|
Base Year |
2024 |
|
Forecast Period |
2025-2032 |
|
Segments |
By Test Type ELISA Assay Enzyme Immunoassay Others |
|
By Application Folate Deficiency Anaemia Pernicious Anaemia Macrocytic Anaemia Others |
|
|
Regional Scope |
North America- United States, Canada, and Mexico Europe – UK, France, Germany, Italy, Spain, Sweden, Russia, and Rest of Europe Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC Middle East and Africa - South Africa, GCC, Egypt, Rest of the Middle East and Africa South America – Brazil, Argentina, Rest of South America |
Active B12 Test Market Key Players:
- Abbott
- Siemens Healthcare Private Limited
- DiaSorin
- Roche
- LifeSpan BioSciences
- Demeditec Diagnostics
- altona Diagnostics
- Pathkind Diagnostics Pvt. Ltd
- Beckman Coulter, Inc.
- Randox Laboratories Ltd.
- Metropolis Healthcare Limited
- Sussex Pathology Limited
- Australian Clinical Labs
- Blue Horizon Blood Tests
- Testing.com
- Lupin Diagnostics
- Humankind Ventures Ltd.
- LalPathLabs.com
- Apollo 24|7
- Medichecks
- XX Inc.
Frequently Asked Questions
Technical and Regulatory Factors are the challenge in the Active B12 Test Market.
The Market size was valued at USD 227.24 Million in 2024 and the total Market revenue is expected to grow at a CAGR of 24.7 % from 2025 to 2032, reaching nearly USD 1328.67 Million.
The segments covered in the market report are by Test Type, and Application.
1. Research Methodology
1.1 Research Data
1.1.1. Primary Data
1.1.2. Secondary Data
1.2. Market Size Estimation
1.2.1. Bottom-Up Approach
1.2.2. Top-Down Approach
1.3. Market Breakdown and Data Triangulation
1.4. Research Assumption
2. Active B12 Test Market: Executive Summary
2.1. Market Overview
2.2. Market Size (2024) and Forecast (2025 – 2032) and Y-O-Y%
2.3. Market Size (USD) and Market Share (%) – By Segments and Regions
3. Global Active B12 Test Market: Competitive Landscape
3.1. SMR Competition Matrix
3.2. Key Players Benchmarking
3.2.1. Company Name
3.2.2. Headquarter
3.2.3. Product Segment
3.2.4. End-user Segment
3.2.5. Y-O-Y%
3.2.6. Revenue (2024)
3.2.7. Profit Margin
3.2.8. Market Share
3.2.9. Company Locations
3.3. Market Structure
3.3.1. Market Leaders
3.3.2. Market Followers
3.3.3. Emerging Players
3.4. Consolidation of the Market
3.4.1. Strategic Initiatives and Developments
3.4.2. Mergers and Acquisitions
3.4.3. Collaborations and Partnerships
4. Active B12 Test Market: Dynamics
4.1. Active B12 Test Market Trends by Region
4.1.1. North America
4.1.2. Europe
4.1.3. Asia Pacific
4.1.4. Middle East and Africa
4.1.5. South America
4.2. Active B12 Test Market Drivers
4.3. Active B12 Test Market Restraints
4.4. Active B12 Test Market Opportunities
4.5. Active B12 Test Market Challenges
4.6. PORTER’s Five Forces Analysis
4.6.1. Intensity of the Rivalry
4.6.2. Threat of New Entrants
4.6.3. Bargaining Power of Suppliers
4.6.4. Bargaining Power of Buyers
4.6.5. Threat of Substitutes
4.7. PESTLE Analysis
4.7.1. Political Factors
4.7.2. Economic Factors
4.7.3. Social Factors
4.7.4. Technological Factor
4.7.5. Legal Factors
4.7.6. Environmental Factors
4.8. Technological Roadmap
4.9. Regulatory Landscape
4.9.1. Market Regulation by Region
4.9.1.1. North America
4.9.1.2. Europe
4.9.1.3. Asia Pacific
4.9.1.4. Middle East and Africa
4.9.1.5. South America
4.9.2. Government Schemes and Initiatives
5. Active B12 Test Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032)
5.1. Active B12 Test Market Size and Forecast, by Test Type (2024-2032)
5.1.1. ELISA Assay
5.1.2. Enzyme Immunoassay
5.1.3. Others
5.2. Active B12 Test Market Size and Forecast, by Application (2024-2032)
5.2.1. Folate Deficiency Anaemia
5.2.2. Pernicious Anaemia
5.2.3. Macrocytic Anaemia
5.2.4. Others
5.3. Active B12 Test Market Size and Forecast, by Region (2024-2032)
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. Middle East and Africa
5.3.5. South America
6. North America Active B12 Test Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032)
6.1. North America Active B12 Test Market Size and Forecast, by Test Type (2024-2032)
6.1.1. ELISA Assay
6.1.2. Enzyme Immunoassay
6.1.3. Others
6.2. North America Active B12 Test Market Size and Forecast, by Application (2024-2032)
6.2.1. Folate Deficiency Anaemia
6.2.2. Pernicious Anaemia
6.2.3. Macrocytic Anaemia
6.2.4. Others
6.3. North America Active B12 Test Market Size and Forecast, by Country (2024-2032)
6.3.1. United States
6.3.2. Canada
6.3.3. Mexico
7. Europe Active B12 Test Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032)
7.1. Europe Active B12 Test Market Size and Forecast, by Test Type (2024-2032)
7.2. Europe Active B12 Test Market Size and Forecast, by Application (2024-2032)
7.3. Europe Active B12 Test Market Size and Forecast, by Country (2024-2032)
7.3.1. United Kingdom
7.3.2. France
7.3.3. Germany
7.3.4. Italy
7.3.5. Spain
7.3.6. Sweden
7.3.7. Austria
7.3.8. Rest of Europe
8. Asia Pacific Active B12 Test Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032)
8.1. Asia Pacific Active B12 Test Market Size and Forecast, by Test Type (2024-2032)
8.2. Asia Pacific Active B12 Test Market Size and Forecast, by Application (2024-2032)
8.3. Asia Pacific Active B12 Test Market Size and Forecast, by Country (2024-2032)
8.3.1. China
8.3.2. S Korea
8.3.3. Japan
8.3.4. India
8.3.5. Australia
8.3.6. Indonesia
8.3.7. Malaysia
8.3.8. Vietnam
8.3.9. Taiwan
8.3.10. Rest of Asia Pacific
9. Middle East and Africa Active B12 Test Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032)
9.1. Middle East and Africa Active B12 Test Market Size and Forecast, by Test Type (2024-2032)
9.2. Middle East and Africa Active B12 Test Market Size and Forecast, by Application (2024-2032)
9.3. Middle East and Africa Active B12 Test Market Size and Forecast, by Country (2024-2032)
9.3.1. South Africa
9.3.2. GCC
9.3.3. Nigeria
9.3.4. Rest of ME&A
10. South America Active B12 Test Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032)
10.1. South America Active B12 Test Market Size and Forecast, by Test Type (2024-2032)
10.2. South America Active B12 Test Market Size and Forecast, by Application (2024-2032)
10.3. South America Active B12 Test Market Size and Forecast, by Country (2024-2032)
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Rest Of South America
11. Company Profile: Key Players
11.1. Abbott
11.1.1. Company Overview
11.1.2. Business Portfolio
11.1.3. Financial Overview
11.1.3.1. Total Revenue
11.1.3.2. Segment Revenue
11.1.3.3. Regional Revenue
11.1.4. SWOT Analysis
11.1.5. Strategic Analysis
11.1.6. Recent Developments
11.2. Siemens Healthcare Private Limited
11.3. DiaSorin
11.4. Roche
11.5. LifeSpan BioSciences
11.6. Demeditec Diagnostics
11.7. altona Diagnostics
11.8. Pathkind Diagnostics Pvt. Ltd
11.9. Beckman Coulter, Inc.
11.10. Randox Laboratories Ltd.
11.11. Metropolis Healthcare Limited
11.12. Sussex Pathology Limited
11.13. Australian Clinical Labs
11.14. Blue Horizon Blood Tests
11.15. Testing.com
11.16. Lupin Diagnostics
11.17. Humankind Ventures Ltd.
11.18. LalPathLabs.com
11.19. Apollo 24|7
11.20. Medichecks
11.21. XX Inc.
12. Key Findings
13. Analyst Recommendations
13.1. Strategic Recommendations
13.2. Future Outlook
